top of page

A progestogen is necessary if there is a uterus or cervix

Unopposed estrogen replacement is associated with a significant increase in the risk of endometrialhyperplasia that is both dose and duration dependent with exposure between one and three years.

​

Non-hysterectomised women require progestogen administered for 12–14 days in a sequentialregimen and daily in a continuous combined regimen to minimise the risk of endometrial hyperplasiaand endometrial cancer associated with unopposed estrogen exposure.

 

 Long-term use of sequential combined HRT for >5 years may be associated with a small increasein risk of endometrial hyperplasia and endometrial cancer, with the risk being dose and durationdependent in relation to progestogen intake.

 

Studies suggest that women taking sequential HRT with less than 10 days of progestogen eachmonth are at increased risk of endometrial hyperplasia and endometrial cancer.

 

 However, progestogen intake in the recommended doses for 12-14 days a month does not appear tobe associated with a significant increase in risk of endometrial hyperplasia for up to 5 years of use.

bottom of page